CSF3, colony stimulating factor 3, 1440

N. diseases: 687; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 Biomarker disease BEFREE In kidney recipients with leukopenia, G-CSF may be helpful to achieve WBC count recovery in addition to changes in immunosuppression and prophylaxis medications. 30887581 2019
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 Biomarker disease BEFREE Then, Nano-DOX was shown to downregulate tumor-derived granulocyte-colony stimulating factor (G-CSF) and suppresses the induction and tissue filtration of myeloid-derived suppressor cells (MDSCs) that are the principal effectors of cancer-associated systemic immunosuppression. 31623629 2019
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 Biomarker disease BEFREE Treatment of severe neutropenia due to other PD1 inhibitors has generally consisted of steroids, granulocyte colony-stimulating factor, intravenous immunoglobulins, mycophenolate mofetil, cyclosporine A, and anti-thymocyte globulins - though the benefits of immunosuppression are not clear and may be harmful given the infectious risks. 29889673 2018
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 Biomarker disease BEFREE Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. 28459367 2017
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 Biomarker disease BEFREE In addition, immunotherapy with G-CSF priming represents a promising therapeutic strategy of targeting the immunosuppression. 28454398 2017
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 Biomarker disease BEFREE Pharmacologic treatments will include chemotherapy agents, antimicrobial agents, as well as granulocyte colony-stimulating factor for immunosuppression. 29099410 2017
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 AlteredExpression disease BEFREE Reported by us and others, G-CSF often induces immunosuppression and down-regulation of response T helper (Th)2 directed immune reaction both in vivo and in vitro. 15214947 2004
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 Biomarker disease BEFREE The use of filgrastim with rapid discontinuation of immunosuppression results in response rates that are similar to results using DLI. 10829047 2000
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.090 GeneticVariation disease BEFREE For this purpose, nine SAA patients, 7 to 46 years old, six of whom were enrolled at diagnosis of their disease and three after previous immunosuppression had failed, were treated with antilymphocyte globulin (ALG) (day 1 to 5), cyclosporin A (5 mg/kg/d orally) (day 6 to 90) and G-CSF 5 micrograms/kg/d (day 6 to 90). 7689868 1993